Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cláudia Maximo"'
Autor:
L. Alexander Liggett, Liam D. Cato, Joshua S. Weinstock, Yingze Zhang, S. Mehdi Nouraie, Mark T. Gladwin, Melanie E. Garrett, Allison Ashley-Koch, Marilyn J. Telen, Brian Custer, Shannon Kelly, Carla L. Dinardo, Ester C. Sabino, Paula Loureiro, Anna B. Carneiro-Proietti, Cláudia Maximo, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Alexander P. Reiner, Gonçalo R. Abecasis, David A. Williams, Pradeep Natarajan, Alexander G. Bick, Vijay G. Sankaran
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 4 (2022)
BACKGROUND Curative gene therapies for sickle cell disease (SCD) are currently undergoing clinical evaluation. The occurrence of myeloid malignancies in these trials has prompted safety concerns. Individuals with SCD are predisposed to myeloid malign
Externí odkaz:
https://doaj.org/article/a86d4c3b616649b781a954f854eda2dc
Autor:
L. Alexander Liggett, Liam D. Cato, Joshua S. Weinstock, Yingze Zhang, S. Mehdi Nouraie, Mark T. Gladwin, Melanie E. Garrett, Allison Ashley-Koch, Marilyn J. Telen, Brian Custer, Shannon Kelly, Carla L. Dinardo, Ester C. Sabino, Paula Loureiro, Anna B. Carneiro-Proietti, Cláudia Maximo, Alexander P. Reiner, Gonçalo R. Abecasis, David A. Williams, Pradeep Natarajan, Alexander G. Bick, Vijay G. Sankaran
Publikováno v:
The Journal of clinical investigation. 132(4)
BACKGROUNDCurative gene therapies for sickle cell disease (SCD) are currently undergoing clinical evaluation. The occurrence of myeloid malignancies in these trials has prompted safety concerns. Individuals with SCD are predisposed to myeloid maligna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950cc7a204b890b48717937cdb50e5d7
https://pubmed.ncbi.nlm.nih.gov/35175224
https://pubmed.ncbi.nlm.nih.gov/35175224
Autor:
André Rolim Belisário, Paula F. Blatyta, Diana Vivanco, Claudia Di Lorenzo Oliveira, Anna Bárbara Carneiro-Proietti, Ester Cerdeira Sabino, Cesar de Almeida-Neto, Paula Loureiro, Cláudia Máximo, Sheila de Oliveira Garcia Mateos, Miriam V. Flor-Park, Daniela de Oliveira Werneck Rodrigues, Rosimere Afonso Mota, Thelma T. Gonçalez, Thomas J. Hoffmann, Shannon Kelly, Brian Custer, for the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) International Component Brazil
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Sickle cell disease (SCD) is a multisystem disorder characterized by a wide spectrum of clinical manifestations and severity. Studies investigating potential effects of co-morbid human immunodeficiency virus (HIV) and SCD have pro
Externí odkaz:
https://doaj.org/article/d7062ca698a44f63b699b8505170f440
Autor:
Kelly Nunes, Vitor R. C. Aguiar, Márcio Silva, Alexandre C. Sena, Danielli C. M. de Oliveira, Carla L. Dinardo, Fernanda S. G. Kehdy, Eduardo Tarazona-Santos, Vanderson G. Rocha, Anna Barbara F. Carneiro-Proietti, Paula Loureiro, Miriam V. Flor-Park, Claudia Maximo, Shannon Kelly, Brian Custer, Bruce S. Weir, Ester C. Sabino, Luís Cristóvão Porto, Diogo Meyer
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
A match of HLA loci between patients and donors is critical for successful hematopoietic stem cell transplantation. However, the extreme polymorphism of HLA loci – an outcome of millions of years of natural selection – reduces the chances that tw
Externí odkaz:
https://doaj.org/article/7135c23b854d4ea48891ccb520ebe641